Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

DOW Chemical at the World Drug Delivery & Formulation Summit 2013

Published: Monday, December 10, 2012
Last Updated: Monday, December 10, 2012
Bookmark and Share
The pharmaceutical industry is experiencing a massive paradigm shift as the era of the highly profitable blockbusters comes to a close.

In an attempt to remain competitive, companies are under more pressure than ever to push novel compounds through the development pipeline and so it has been largely left to those in formulation and delivery to optimise their product portfolio using winning business strategies and leading technologies.

Entering its 4th consecutive year, the World Drug Delivery & Formulation Summit informs attendees of leading industry updates, strategies and technologies through technical workshops, case studies and presentations. It equips delegates with the tools and the know-how they need to launch new products, reformulate existing drugs and to remain both patient and regulatory compliant.

The three day summit is structured into three distinct streams that focus on leading issues and challenges in the small molecule, biological and technology space respectively. These include innovative formulation technologies, routes of delivery, advances in drug delivery devices and best practices in supporting the sourcing and management of partnering relationships.

We are thrilled that Dow Chemical will be attending both as our Lead Category Sponsor for Solubilisation and as Chairman for our leading technology day. We look forward to hearing from them during their interactive session on Monday 18th February 2013.

Exclusive sessions include:

•    Preventing the Demise of the Research-driven Pharmaceutical Industry Model
•    Driving Development in Extreme Population Groups – Geriatrics & Paediatrics
•    Evolving Controlled Release Technologies to Support the Next Generation of Drug Delivery
•    Novel Concepts in Pharmaceutical Analysis in Supporting Formulation
•    Understanding and Developing the Science Behind Oral Protein Delivery
•    Optimising the Delivery of Peptide Therapeutics
•    Adopting Open Innovation to Ensure Continued Growth and Success in Pharma Development

For the full programme, visit www.ddfevent.comprogramme.

This summit agenda is researched and produced with the help of drug delivery and formulation experts to reflect the latest industry news, technologies and advancements.  Additionally we facilitate pre-arranged one-to-one meetings onsite between yourselves and leading service and technology providers, hand-picked to suit your personal needs.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
CRISPR-Cas9 Gene Editing: Check Three Times, Cut Once
Two new studies from UC Berkeley should give scientists who use CRISPR-Cas9 for genome engineering greater confidence that they won’t inadvertently edit the wrong DNA.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos